82 related articles for article (PubMed ID: 15799960)
1. Identifying modulators of hERG channel activity using the PatchXpress planar patch clamp.
Dubin AE; Nasser N; Rohrbacher J; Hermans AN; Marrannes R; Grantham C; Van Rossem K; Cik M; Chaplan SR; Gallacher D; Xu J; Guia A; Byrne NG; Mathes C
J Biomol Screen; 2005 Mar; 10(2):168-81. PubMed ID: 15799960
[TBL] [Abstract][Full Text] [Related]
2. Assessing hERG channel inhibition using PatchXpress.
Ly JQ; Shyy G; Misner DL
Clin Lab Med; 2007 Mar; 27(1):201-8. PubMed ID: 17416313
[TBL] [Abstract][Full Text] [Related]
3. Automated electrophysiology in the preclinical evaluation of drugs for potential QT prolongation.
Guo L; Guthrie H
J Pharmacol Toxicol Methods; 2005; 52(1):123-35. PubMed ID: 15936217
[TBL] [Abstract][Full Text] [Related]
4. Application of PatchXpress planar patch clamp technology to the screening of new drug candidates for cardiac KCNQ1/KCNE1 (I Ks) activity.
Trepakova ES; Malik MG; Imredy JP; Penniman JR; Dech SJ; Salata JJ
Assay Drug Dev Technol; 2007 Oct; 5(5):617-27. PubMed ID: 17939752
[TBL] [Abstract][Full Text] [Related]
5. IonFlux: a microfluidic patch clamp system evaluated with human Ether-à-go-go related gene channel physiology and pharmacology.
Golden AP; Li N; Chen Q; Lee T; Nevill T; Cao X; Johnson J; Erdemli G; Ionescu-Zanetti C; Urban L; Holmqvist M
Assay Drug Dev Technol; 2011 Dec; 9(6):608-19. PubMed ID: 21561375
[TBL] [Abstract][Full Text] [Related]
6. Novel 384-well population patch clamp electrophysiology assays for Ca2+-activated K+ channels.
John VH; Dale TJ; Hollands EC; Chen MX; Partington L; Downie DL; Meadows HJ; Trezise DJ
J Biomol Screen; 2007 Feb; 12(1):50-60. PubMed ID: 17092914
[TBL] [Abstract][Full Text] [Related]
7. Improved throughput of PatchXpress hERG assay using intracellular potassium fluoride.
Zeng H; Penniman JR; Kinose F; Kim D; Trepakova ES; Malik MG; Dech SJ; Balasubramanian B; Salata JJ
Assay Drug Dev Technol; 2008 Apr; 6(2):235-41. PubMed ID: 18471077
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a hERG screen using the IonWorks HT: comparison to a hERG rubidium efflux screen.
Sorota S; Zhang XS; Margulis M; Tucker K; Priestley T
Assay Drug Dev Technol; 2005 Feb; 3(1):47-57. PubMed ID: 15798395
[TBL] [Abstract][Full Text] [Related]
9. High throughput ion-channel pharmacology: planar-array-based voltage clamp.
Kiss L; Bennett PB; Uebele VN; Koblan KS; Kane SA; Neagle B; Schroeder K
Assay Drug Dev Technol; 2003 Feb; 1(1 Pt 2):127-35. PubMed ID: 15090139
[TBL] [Abstract][Full Text] [Related]
10. Effect of compound plate composition on measurement of hERG current IC(50) using PatchXpress.
Mo ZL; Faxel T; Yang YS; Gallavan R; Messing D; Bahinski A
J Pharmacol Toxicol Methods; 2009; 60(1):39-44. PubMed ID: 19442753
[TBL] [Abstract][Full Text] [Related]
11. Automated voltage-clamp technique.
Ghetti A; Guia A; Xu J
Methods Mol Biol; 2007; 403():59-69. PubMed ID: 18827987
[TBL] [Abstract][Full Text] [Related]
12. Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT.
Bridgland-Taylor MH; Hargreaves AC; Easter A; Orme A; Henthorn DC; Ding M; Davis AM; Small BG; Heapy CG; Abi-Gerges N; Persson F; Jacobson I; Sullivan M; Albertson N; Hammond TG; Sullivan E; Valentin JP; Pollard CE
J Pharmacol Toxicol Methods; 2006; 54(2):189-99. PubMed ID: 16563806
[TBL] [Abstract][Full Text] [Related]
13. Block effect of capsaicin on hERG potassium currents is enhanced by S6 mutation at Y652.
Xing J; Ma J; Zhang P; Fan X
Eur J Pharmacol; 2010 Mar; 630(1-3):1-9. PubMed ID: 19903464
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological removal of human ether-à-go-go-related gene potassium channel inactivation by 3-nitro-N-(4-phenoxyphenyl) benzamide (ICA-105574).
Gerlach AC; Stoehr SJ; Castle NA
Mol Pharmacol; 2010 Jan; 77(1):58-68. PubMed ID: 19805508
[TBL] [Abstract][Full Text] [Related]
15. Estimation of potency of HERG channel blockers: impact of voltage protocol and temperature.
Yao JA; Du X; Lu D; Baker RL; Daharsh E; Atterson P
J Pharmacol Toxicol Methods; 2005; 52(1):146-53. PubMed ID: 15936218
[TBL] [Abstract][Full Text] [Related]
16. Population patch-clamp electrophysiology analysis of recombinant GABAA alpha1beta3gamma2 channels expressed in HEK-293 cells.
Hollands EC; Dale TJ; Baxter AW; Meadows HJ; Powell AJ; Clare JJ; Trezise DJ
J Biomol Screen; 2009 Aug; 14(7):769-80. PubMed ID: 19556611
[TBL] [Abstract][Full Text] [Related]
17. Introduction of a modular automated voltage-clamp platform and its correlation with manual human Ether-à-go-go related gene voltage-clamp data.
Scheel O; Himmel H; Rascher-Eggstein G; Knott T
Assay Drug Dev Technol; 2011 Dec; 9(6):600-7. PubMed ID: 21675869
[TBL] [Abstract][Full Text] [Related]
18. 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels.
Gordon E; Lozinskaya IM; Lin Z; Semus SF; Blaney FE; Willette RN; Xu X
Mol Pharmacol; 2008 Mar; 73(3):639-51. PubMed ID: 18042732
[TBL] [Abstract][Full Text] [Related]
19. Potent inhibition of human cardiac potassium (HERG) channels by the anti-estrogen agent clomiphene-without QT interval prolongation.
Yuill KH; Borg JJ; Ridley JM; Milnes JT; Witchel HJ; Paul AA; Kozlowski RZ; Hancox JC
Biochem Biophys Res Commun; 2004 May; 318(2):556-61. PubMed ID: 15120636
[TBL] [Abstract][Full Text] [Related]
20. Blockade of hERG K(+) channel by antimalarial drug, primaquine.
Kim KS; Lee HA; Cha SW; Kwon MS; Kim EJ
Arch Pharm Res; 2010 May; 33(5):769-73. PubMed ID: 20512476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
